OptiNose
OPTN
#9289
Rank
โ‚ฌ82.91 M
Marketcap
8,19ย โ‚ฌ
Share price
0.00%
Change (1 day)
-49.31%
Change (1 year)

Revenue for OptiNose (OPTN)

Revenue in 2025 (TTM): โ‚ฌ76.09 Million

According to OptiNose's latest financial reports the company's current revenue (TTM ) is โ‚ฌ69.8 Million. In 2024 the company made a revenue of โ‚ฌ75.17 Million an increase over the revenue in the year 2023 that were of โ‚ฌ64.21 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for OptiNose from 2017 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ76.09 M1.22%
2024 โ‚ฌ75.17 M17.06%
2023 โ‚ฌ64.21 M-9.69%
2022 โ‚ฌ71.1 M7.87%
2021 โ‚ฌ65.91 M65.07%
2020 โ‚ฌ39.93 M29.17%
2019 โ‚ฌ30.91 M400.65%
2018 โ‚ฌ6.17 M
2017 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Onconova Therapeutics
ONTX
โ‚ฌ0.19 M-99.72%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
โ‚ฌ0.54 B 684.38%๐Ÿ‡บ๐Ÿ‡ธ USA